Cite
Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity
MLA
Zhifang Guo, et al. “Aquaporin 1 Promotes Sensitivity of Anthracycline Chemotherapy in Breast Cancer by Inhibiting β-Catenin Degradation to Enhance TopoIIα Activity.” Cell Death and Differentiation, vol. 28, no. 1, Aug. 2020, pp. 382–400. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7be229ec00bfd87736fb3eae2a659807&authtype=sso&custid=ns315887.
APA
Zhifang Guo, Limin Yang, Wei Chong, Xiaoli Liu, Ming Zhang, Feng Gu, Yongjie Ma, Yawen Zhao, Caixia Guo, Huikun Zhang, Zhe Wang, Li Fu, & Ying Shao. (2020). Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity. Cell Death and Differentiation, 28(1), 382–400.
Chicago
Zhifang Guo, Limin Yang, Wei Chong, Xiaoli Liu, Ming Zhang, Feng Gu, Yongjie Ma, et al. 2020. “Aquaporin 1 Promotes Sensitivity of Anthracycline Chemotherapy in Breast Cancer by Inhibiting β-Catenin Degradation to Enhance TopoIIα Activity.” Cell Death and Differentiation 28 (1): 382–400. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7be229ec00bfd87736fb3eae2a659807&authtype=sso&custid=ns315887.